Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
Zhao L, Zhang Y, Liu F, Yang H, Zhong Y, Wang Y, Li S, Su Q, Tang L, Bai L, Ren H, Zou Y, Wang S, Zheng S, Xu H, Li L, Zhang J, Chai Z, Cooper ME, Tong N.
Zhao L, et al. Among authors: bai l.
J Endocrinol Invest. 2021 Dec;44(12):2709-2723. doi: 10.1007/s40618-021-01596-3. Epub 2021 May 27.
J Endocrinol Invest. 2021.
PMID: 34043214
Free PMC article.